drugset / Trial / NCT04595981
Chemo-embolization for Head and Neck Cancer
NaSingle-groupOpen-labelTreatment
Summary
The study will evaluate whether adjuvant chemo-embolization increases progression free and/or overall survival relative to standard of care radiation and chemo- and/or immunotherapy in cisplatin-ineligible head and neck cancer patients with an acceptable morbidity rate.
Timeline
- Start
- 2027-05
- Primary completion
- 2029-05
- Completion
- 2030-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 150 mg | Other |
| Subject | Cisplatin | Other / unclassified | 150 mg/m2 | Other |
| Subject | Cisplatin | Other / unclassified | 300 mg | Other |